Reduced AKT/mTOR signaling and protein synthesis dysregulation has been described in the brain of the MeCP2 KO Rett syndrome animal model, thus indicating that MeCP2 is an upstream regulator of the Akt/mTOR pathway (Ricciardi et al., 2011). The gene discussed is MTOR; the disease is atypical Rett syndrome.